Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

UBLITUXIMAB for Follicular lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where UBLITUXIMAB was used for Follicular lymphoma.

Most Reported Side Effects for UBLITUXIMAB

Side Effect Reports % Deaths Hosp.
Infusion related reaction 538 34.0% 0 21
Fatigue 110 7.0% 1 9
Headache 55 3.5% 1 5
Inappropriate schedule of product administration 53 3.4% 1 0
Malaise 49 3.1% 0 3
Multiple sclerosis relapse 48 3.0% 1 18
Asthenia 45 2.8% 0 7
Pain 45 2.8% 0 5
Illness 43 2.7% 0 4
Urinary tract infection 42 2.7% 2 13
Covid-19 39 2.5% 1 11
Gait disturbance 37 2.3% 0 5
Nasopharyngitis 37 2.3% 1 3
Nausea 37 2.3% 1 4
Pain in extremity 37 2.3% 1 7

Other Indications for UBLITUXIMAB

Multiple sclerosis (1,455) Chronic lymphocytic leukaemia (62) Non-hodgkin's lymphoma (17) Product used for unknown indication (12) Relapsing multiple sclerosis (11) B-cell lymphoma (7)

Other Drugs Used for Follicular lymphoma

LENALIDOMIDE (3,611) RITUXIMAB (3,294) OBINUTUZUMAB (2,527) BENDAMUSTINE (1,560) CYCLOPHOSPHAMIDE (1,367) VINCRISTINE (1,224) DOXORUBICIN (1,115) PREDNISONE (889) TAZEMETOSTAT HYDROBROMIDE (439) ETOPOSIDE (352)

Related Pages

UBLITUXIMAB Full Profile All Follicular lymphoma Drugs UBLITUXIMAB Demographics UBLITUXIMAB Timeline